University of Malaya, Malaysia
Assoc. Prof. Dr. Nirmala Bhoo-Pathy is currently an associate professor of epidemiology in the Faculty of Medicine, University of Malaya, and a visiting lecturer at Queen’s University Belfast, United Kingdom.
Assoc. Prof. Dr Bhoo-Pathy graduated as a medical doctor from the University of Malaya. Following a fellowship award from the European Union, she completed her master’s degree in clinical epidemiology, cum laude, and a PhD in cancer epidemiology from the University of Utrecht, Netherlands.
Her career is focused on optimising life after cancer through research on cancer survival, treatment outcomes and patient-centred outcomes in Asia. Assoc. Prof. Dr Bhoo-Pathy is the principal investigator of phase III of the ACTION (ASEAN Costs in Oncology) study, which comprises nearly 10,000 cancer patients from eight member countries of the Association of South-East Asian Nations. This study is expected to provide evidence for South-east Asian nations to prioritise policies that will reduce financial loss and premature deaths associated with cancer.
Policy & Priorities for National Cancer Control Planning in Low & Middle Income Countries: Lessons from the ASEAN Costs in Oncology, ACTION Study
Evidence to guide policymakers in developing affordable and equitable cancer control plans are scarce in low- and middle-income countries (LMIC). The ACTION (ASEAN Costs in Oncology) study, examined the human cost of cancer to populations across eight countries in Southeast Asia (Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Thailand and Vietnam). The study was designed to assess the impact of cancer on household economic wellbeing and patients’ survival as well as quality of life. In this talk, findings from the overall study, and findings specific to Malaysia will be presented, and the policy implications will be discussed.